Follow
Alejandro Carpy
Alejandro Carpy
Roche Pharma Research and Early Development
Verified email at roche.com
Title
Cited by
Cited by
Year
Absolute proteome and phosphoproteome dynamics during the cell cycle of Schizosaccharomyces pombe (Fission Yeast)
A Carpy, K Krug, S Graf, A Koch, S Popic, S Hauf, B Macek
Molecular & Cellular Proteomics 13 (8), 1925-1936, 2014
1602014
IAPs regulate the plasticity of cell migration by directly targeting Rac1 for degradation
TK Oberoi, T Dogan, JC Hocking, RP Scholz, J Mooz, CL Anderson, ...
The EMBO journal 31 (1), 14-28, 2012
1452012
Global detection of protein kinase D-dependent phosphorylation events in nocodazole-treated human cells
M Franz-Wachtel, SA Eisler, K Krug, S Wahl, A Carpy, A Nordheim, ...
Molecular & Cellular Proteomics 11 (5), 160-170, 2012
962012
Deep coverage of the Escherichia coli proteome enables the assessment of false discovery rates in simple proteogenomic experiments
K Krug, A Carpy, G Behrends, K Matic, NC Soares, B Macek
Molecular & cellular proteomics 12 (11), 3420-3430, 2013
802013
Differential Rac1 signalling by guanine nucleotide exchange factors implicates FLII in regulating Rac1-driven cell migration
H Marei, A Carpy, A Woroniuk, C Vennin, G White, P Timpson, B Macek, ...
Nature communications 7 (1), 10664, 2016
762016
Targeting intracellular WT1 in AML with a novel RMF-peptide-MHC-specific T-cell bispecific antibody
C Augsberger, G Hänel, W Xu, V Pulko, LJ Hanisch, A Augustin, J Challier, ...
Blood, The Journal of the American Society of Hematology 138 (25), 2655-2669, 2021
482021
Ubiquitin‐dependent regulation of MEKK 2/3‐MEK 5‐ERK 5 signaling module by XIAP and c IAP 1
AN Takeda, TK Oberoi‐Khanuja, G Glatz, K Schulenburg, RP Scholz, ...
The EMBO journal 33 (16), 1784-1801, 2014
31*2014
Ubiquitin-dependent regulation of Cdc42 by XIAP
A Murali, J Shin, H Yurugi, A Krishnan, M Akutsu, A Carpy, B Macek, ...
Cell death & disease 8 (6), e2900-e2900, 2017
242017
Construction and assessment of individualized proteogenomic databases for large‐scale analysis of nonsynonymous single nucleotide variants
K Krug, S Popic, A Carpy, C Taumer, B Macek
Proteomics 14 (23-24), 2699-2708, 2014
232014
Proteomic analysis of Rac1 signaling regulation by guanine nucleotide exchange factors
H Marei, A Carpy, B Macek, A Malliri
Cell Cycle 15 (15), 1961-1974, 2016
202016
Nic1 inactivation enables stable isotope labeling with 13C615N4-arginine in Schizosaccharomyces pombe
A Carpy, A Patel, YD Tay, IM Hagan, B Macek
Molecular & Cellular Proteomics 14 (1), 243-250, 2015
82015
Stable isotope labeling by amino acids in cell culture (SILAC) technology in fission yeast
B Maček, A Carpy, A Koch, CC Bicho, WE Borek, S Hauf, KE Sawin
Cold Spring Harbor Protocols 2017 (6), pdb. top079814, 2017
72017
Targeting Intracellular WT1 in AML utilizing a T cell bispecific antibody construct: augmenting efficacy through combination with lenalidomide
C Klein, C Augsberger, W Xu, C Heitmueller, L Hanisch, J Sam, V Pulko, ...
Blood 134, 4450, 2019
62019
RG6234: a novel 2: 1 GPRC5D T cell bispecific antibody exhibits best in class potential for the treatment of multiple myeloma as a monotherapy and in combination
J Eckmann, T Fauti, A Zabaleta, L Blanco, S Kassem, N Carrié, S Lorenz, ...
Blood 140 (Supplement 1), 2091-2092, 2022
52022
Construction, growth, and harvesting of fission yeast stable isotope labeling by amino acids in cell culture (SILAC) strains
A Koch, CC Bicho, WE Borek, A Carpy, B Maček, S Hauf, KE Sawin
Cold Spring Harbor Protocols 2017 (6), pdb. prot091678, 2017
52017
Immune-infiltrated kidney organoid-on-chip model for assessing T cell bispecific antibodies
KT Kroll, MM Mata, KA Homan, V Micallef, A Carpy, K Hiratsuka, ...
Proceedings of the National Academy of Sciences 120 (35), e2305322120, 2023
42023
Stable isotope labeling by amino acids in cell culture (SILAC)-based quantitative proteomics and phosphoproteomics in fission yeast
A Carpy, A Koch, CC Bicho, WE Borek, S Hauf, KE Sawin, B Maček
Cold Spring Harbor Protocols 2017 (6), pdb. prot091686, 2017
32017
The physiological interactome of TCR-like antibody therapeutics in human tissues
E Marrer-Berger, A Nicastri, A Augustin, V Kramar, H Liao, LJ Hanisch, ...
Nature Communications 15 (1), 3271, 2024
2024
Targeting of intracellular WT1 with a T-cell bispecific antibody in AML
G Haenel, C Augsberger, W Xu, V Pulko, J Sam, A Ducret, ...
ONCOLOGY RESEARCH AND TREATMENT 44, 31-31, 2021
2021
PF207 TARGETING WILMS TUMOR 1 WITH AT CELL BISPECIFIC ANTIBODY (WT1‐TCB): EX VIVO AND IN VIVO POTENCY BY BIVALENT RECOGNITION OF PEPTIDE‐MHC COMPLEXES FROM AN INTRACELLULAR …
C Augsberger, C Klein, C Heitmüller, W Xu, LJ Hanisch, J Sam, V Pulko, ...
HemaSphere 3, 56, 2019
2019
The system can't perform the operation now. Try again later.
Articles 1–20